Table 2.
Site | No. of recurrences |
All 177 patients with a recurrence, %* |
All 306 patients, % |
---|---|---|---|
Local | |||
Liver hilum | 34 | 19 | 11 |
Hepaticojejunostomy | 23 | 13 | 8 |
Distal bile duct remnant | 6 | 3 | 2 |
Liver resection margin | 23 | 13 | 8 |
Distant | |||
Liver intrahepatic | 40 | 23 | 13 |
Retroperitoneal lymph nodes† | 42 | 24 | 14 |
Peritoneum* | 38 | 21 | 12 |
Lung or mediastinum | 25 | 14 | 8 |
Abdominal wall/incision | 8 | 5 | 2 |
Bone | 3 | 2 | 1 |
Skin | 1 | 1 | 0 |
Adrenal gland | 1 | 1 | 0 |
Axillary or neck lymph nodes | 2 | 1 | 1 |
Spleen | 1 | 1 | 0 |
Totals | |||
Recurrences, no. | 245 | ||
Patients with a recurrence, n | 177 | 58 | |
Patients with an intial local recurrence, n | 81 | 26 | |
Patients with an initial isolated local recurrence, n | 54 | 18 | |
Patients with an initial distal recurrence, n | 123 | 40 |
Note that patients can have an initial recurrence at more than one site. Consequently, total percentage of recurrence across all sites exceeds 100%.
Includes positive cytology of ascites and omental metastases.
Includes periaortic, pericaval, and celiac artery lymph nodes.